Nancy Wedel

1.3k total citations
23 papers, 939 citations indexed

About

Nancy Wedel is a scholar working on Immunology, Surgery and Molecular Biology. According to data from OpenAlex, Nancy Wedel has authored 23 papers receiving a total of 939 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 5 papers in Surgery and 5 papers in Molecular Biology. Recurrent topics in Nancy Wedel's work include Immune Response and Inflammation (4 papers), S100 Proteins and Annexins (4 papers) and Renal Transplantation Outcomes and Treatments (3 papers). Nancy Wedel is often cited by papers focused on Immune Response and Inflammation (4 papers), S100 Proteins and Annexins (4 papers) and Renal Transplantation Outcomes and Treatments (3 papers). Nancy Wedel collaborates with scholars based in United States, Netherlands and Canada. Nancy Wedel's co-authors include Betty J Nelson, Lynn E. S̄pitler, L.L. Miller, R P Mischak, Archie Khentigan, David A. Scheinberg, Eric J. Feldman, Philip Schulman, Maguy Del Rio and N A Brophy and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Journal of the American College of Cardiology.

In The Last Decade

Nancy Wedel

22 papers receiving 895 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nancy Wedel United States 13 493 266 189 170 163 23 939
R. van Furth Netherlands 17 505 1.0× 366 1.4× 248 1.3× 86 0.5× 79 0.5× 29 1.2k
Margot O’Toole United States 14 757 1.5× 178 0.7× 149 0.8× 104 0.6× 52 0.3× 28 1.2k
Ina S. Klasen Netherlands 18 519 1.1× 251 0.9× 232 1.2× 80 0.5× 68 0.4× 45 1.1k
Patrick Isler Switzerland 16 573 1.2× 181 0.7× 147 0.8× 169 1.0× 48 0.3× 24 1.1k
H. C. Hoogsteden Netherlands 21 537 1.1× 150 0.6× 179 0.9× 57 0.3× 20 0.1× 37 1.2k
Scott A. Siegel United States 12 350 0.7× 242 0.9× 149 0.8× 150 0.9× 149 0.9× 21 1.1k
Mayuko Tamura Japan 10 261 0.5× 140 0.5× 226 1.2× 32 0.2× 134 0.8× 26 639
Dorothy B. Windhorst United States 18 626 1.3× 303 1.1× 121 0.6× 32 0.2× 238 1.5× 33 1.3k
Erik Lindh Sweden 16 175 0.4× 251 0.9× 195 1.0× 120 0.7× 28 0.2× 23 905
N Génetet France 18 509 1.0× 261 1.0× 205 1.1× 45 0.3× 140 0.9× 54 1.0k

Countries citing papers authored by Nancy Wedel

Since Specialization
Citations

This map shows the geographic impact of Nancy Wedel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nancy Wedel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nancy Wedel more than expected).

Fields of papers citing papers by Nancy Wedel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nancy Wedel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nancy Wedel. The network helps show where Nancy Wedel may publish in the future.

Co-authorship network of co-authors of Nancy Wedel

This figure shows the co-authorship network connecting the top 25 collaborators of Nancy Wedel. A scholar is included among the top collaborators of Nancy Wedel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nancy Wedel. Nancy Wedel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wedel, Nancy, et al.. (2024). Hybrid repair of aortic aneurysm in a patient with a congenital pelvic kidney. Journal of Vascular Surgery Cases and Innovative Techniques. 11(2). 101708–101708.
2.
Dalenbäck, J., Carina Andersson, S Björck, et al.. (2008). Prolene Hernia System, Lichtenstein mesh and plug-and-patch for primary inguinal hernia repair: 3-year outcome of a prospective randomised controlled trial. Hernia. 13(2). 121–129. 34 indexed citations
3.
4.
Feldman, Eric J., M Kalaycio, George J. Weiner, et al.. (2003). Treatment of relapsed or refractory acute myeloid leukemia with humanized anti-CD33 monoclonal antibody HuM195. Leukemia. 17(2). 314–318. 66 indexed citations
5.
Meijer, Catharina, Marinus J. Wiezer, Erik Hack, et al.. (2001). COAGULOPATHY FOLLOWING MAJOR LIVER RESECTION: THE EFFECT OF rBPI21 AND THE ROLE OF DECREASED SYNTHESIS OF REGULATING PROTEINS BY THE LIVER. Shock. 15(4). 261–271. 11 indexed citations
6.
Norman, Douglas J., Flavio Vincenti, Angelo M. de Mattos, et al.. (2000). PHASE I TRIAL OF HuM291, A HUMANIZED ANTI-CD3 ANTIBODY, IN PATIENTS RECEIVING RENAL ALLOGRAFTS FROM LIVING DONORS1. Transplantation. 70(12). 1707–1712. 42 indexed citations
7.
Bauer, Robert J., et al.. (1999). Pharmacokinetics of a Recombinant Modified Amino Terminal Fragment of Bactericidal/Permeability‐Increasing Protein (rBPI21) in Healthy Volunteers. The Journal of Clinical Pharmacology. 39(11). 1169–1176. 7 indexed citations
8.
Giroir, Brett P., Phil Barton, Erica A. Kirsch, et al.. (1997). Preliminary evaluation of recombinant amino-terminal fragment of human bactericidal/permeability-increasing protein in children with severe meningococcal sepsis. The Lancet. 350(9089). 1439–1443. 140 indexed citations
9.
10.
Winter, Robbert J. de, et al.. (1995). 916-91 Recombinant Endotoxin-binding Protein (rBPI23) Attenuates Endotoxin-induced Circulatory Changes in Humans. Journal of the American College of Cardiology. 25(2). 76A–76A. 11 indexed citations
11.
Wong, Hector R., Lesley Doughty, Nancy Wedel, et al.. (1995). Plasma bactericidal/permeability-increasing protein concentrations in critically ill children with the sepsis syndrome. The Pediatric Infectious Disease Journal. 14(12). 1087–1090. 17 indexed citations
12.
Kimmings, A N, Nancy Wedel, Marcel L.C.M. Mevissen, et al.. (1995). Inhibition of Endotoxin-Induced Cytokine Release and Neutrophil Activation in Humans by Use of Recombinant Bactericidal/Permeability-Increasing Protein. The Journal of Infectious Diseases. 172(1). 144–151. 98 indexed citations
13.
Winter, Rob J. de, Nancy Wedel, Betty J Nelson, et al.. (1995). Recombinant endotoxin-binding protein (rBPI23) attenuates endotoxin-induced circulatory changes in humans.. PubMed. 45(3). 193–206. 18 indexed citations
14.
Selvaggi, Kathy, Elizabeth A. Saria, R H Schwartz, et al.. (1993). Phase I/II Study of Murine Monoclonal Antibody-Ricin A Chain (XOMAZYME-Mel) Immunoconjugate plus Cyclosporine A in Patients with Metastatic Melanoma. Journal of Immunotherapy. 13(3). 201–207. 42 indexed citations
15.
Greenberg, Richard N., et al.. (1992). Observations using antiendotoxin antibody (E5) as adjuvant therapy in humans with suspected, serious, Gram-negative sepsis. Critical Care Medicine. 20(6). 730–735. 26 indexed citations
16.
González, René, P Salem, Paul A. Bunn, et al.. (1991). Single-dose murine monoclonal antibody ricin A chain immunotoxin in the treatment of metastatic melanoma: a phase I trial.. PubMed. 3(4). 192–6. 12 indexed citations
17.
S̄pitler, Lynn E., Maguy Del Rio, Archie Khentigan, et al.. (1987). Therapy of patients with malignant melanoma using a monoclonal antimelanoma antibody-ricin A chain immunotoxin.. PubMed. 47(6). 1717–23. 167 indexed citations
18.
Berglin, Eva, I Blohmé, H. Persson, et al.. (1984). Clinical experience of blood transfusion in renal transplantation.. PubMed. 88. 1–69. 3 indexed citations
19.
Brynger, H, et al.. (1981). Blood transfusion in cadaveric renal transplantation-a prospective study.. PubMed. 64. 100–5. 2 indexed citations
20.
Wedel, Nancy, H Brynger, & I Blohmé. (1980). Kidney transplantation in patients 60 years and older.. PubMed. 54. 106–8. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by R. van Furth Breakdown of academic impact, for papers by Margot O’Toole Breakdown of academic impact, for papers by Ina S. Klasen Breakdown of academic impact, for papers by Patrick Isler Breakdown of academic impact, for papers by H. C. Hoogsteden Breakdown of academic impact, for papers by Scott A. Siegel Breakdown of academic impact, for papers by Mayuko Tamura Breakdown of academic impact, for papers by Dorothy B. Windhorst Breakdown of academic impact, for papers by Erik Lindh Breakdown of academic impact, for papers by N Génetet
Rankless by CCL
2026